Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-01-18
2005-01-18
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S211090, C514S217060, C514S218000, C514S232200, C514S235800, C540S544000, C540S545000, C540S601000, C544S058600, C544S060000, C544S082000, C544S122000, C544S295000, C544S326000, C544S327000, C544S329000
Reexamination Certificate
active
06844347
ABSTRACT:
The invention relates to compounds of formula I,in which R1, R2, R3and R4have the meanings given in the claims. Said compounds are valuable active ingredients for the treatment and prophylaxis of diseases, for example of cardiovascular diseases such as hypertension, angina pectoris, heart failure, thrombosis or atherosclerosis. The compounds of the formula I are able to modulate the body's production of cyclic guanosine monophosphate (cGMP) and are generally suitable for the treatment and prophylaxis of disorders associated with impaired cGMP balance. The invention furthermore relates to methods for producing compounds of the formula I, their use in the treatment and prophylaxis of the above diseases and in the preparation of medicaments for such diseases, and pharmaceutical preparations containing the compounds of formula I.
REFERENCES:
patent: 4493726 (1985-01-01), Burdeska et al.
patent: 6162819 (2000-12-01), Schindler et al.
patent: 4034762 (1992-05-01), None
patent: 19744027 (1999-04-01), None
patent: 19756388 (1999-06-01), None
patent: 0 055 693 (1980-12-01), None
patent: 0 136 976 (1985-04-01), None
patent: 0 555 478 (1993-08-01), None
patent: 0 908 456 (1999-04-01), None
patent: 06-192252 (1994-07-01), None
patent: WO 9837079 (1998-08-01), None
Morel et al., Chemical Abstracts, vol. 125:221520, 1995.*
Brown et al., Chemical Abstracts, vol. 100:209733, 1984.*
Abstract for German Patent No. DE 19744027 A1, Schindler et al., “New Pyrazolo(3,4-b)pyridine Derivatives Useful as cGMP Agonists”, Derwent WPI database, no date.
Abstract for German Patent No. DE 4034762 A, Braun et al., “Pyridyl Pyrimidine Derivs. are Fungicides for Plant Protection and for Protecting and preserving Industrial Materials”, Derwent WPI database, no date.
Abstract for German Patent No. DE 19756388 A, Schindler et al., “New 2-aryl-4-amino-6,7-dimethoxy-quinazoline Derivatives Useful as Guanylate Cycloase Activators for Treating Cardiovascular Diseases, etc.”, Derwent WPI database, no date.
Ignarro, Louis J., “Regulation of Cytosolic Guanylyl Cyclase by Porphyrins and Metalloporphyrins,”Advances in Pharmacology 26:35-65 (1994).
Abstract for Japanes Patent No. 06192252, Ito Yoichi, “Pyrazine Derivative and Herbicide”, Patent Abstracts of Japan. no date.
Abstract for EP Patent No. EP0136976, Seiler Alfred et al, “Use of Phenyl Pyrimidines as Plant Regulators”, esp@cenet database, no date.
Nikolaenkova E.B. et al., “Synthesis of 4,6-Bis(1H,2,3-Triazolyl)Pyrimidines by the Reaction of 4,6-Diazido-2-(4-Methoxyphenyl)-Pyrimidine with Compounds Containing a Reactive Methylene Group,”Chemistry of Heterocyclic Compounds 33(8):968-972 (1998).
Mülsch, Alexander et al., “Purification of Heme-Containing Soluble Guanylyl Cyclase,”Methods in Enzymology 195:377-383 (1991).
Ko, Feng-Nien et al., “YC-1, a Novel Activator of Platelet Guanylate Cyclase,”Blood 84(12):4226-1233 (1994).
Vesely, David L., “Phencyclidine Stimulates Guanylate Cyclase Activity,”Biochemical and Biophysical Research Communications 88(4):1244-1248 (1979).
Vesely, D.L., et al., “B Complex Vitiamins Activate Rat Guanylate Cyclase and Increase Cyclic GMP Levels,”European Journal of Clinical Investigation 15:258-262 (1985).
Pettibone, D.J., et al., “A Structurally Novel Stimulator of Guanylate Cyclase with Long-Lasting Hypotensive Activity in the Dog,”European Journal of Pharmacology 116:307-312 (1985).
Yu, S-M., et al., “Vasorelaxant Effect of Isoliquiritigenin, a Novel Soluble Guanylate Cyclaes Activator, in Rat Aorta,”British Journal of Phramacology 114:1587-1594 (1995).
Yu, S-M., et al., “Mechanism of Anti-Proliferation Caused by YC-1, an Indazole Derivative, in Cultured Rat A10 Vascular Smooth-Muscle Cells,”Biochem. J. 306:787-792 (1995).
Wu, Chin-Chung et al., “YC-1 Inhibited Human Platelet Aggregation Through NO-Independent Activation of Soluble Guanylate Cyclase,”British Journal of Pharmacology 116:1973-1978 (1995).
Ignarro, Louis J., “Regulation of Cytosolic Guanylyl Cyclase by Porphyrins and Metalloporphyrins,”Advances in Pharmacology 26:35-65 (1994).
Abstract for Japanese Patent No. 06192252, Ito Yoichi, “Pyrazine Derivative and Herbicide”, Patent Abstracts of Japan (Jul. 12, 1994).
Abstract for EP Patent No. EP0136976, Seiler Alfred et al., “Use of Phenyl Pyrimidines as Plant Regulators”, esp@cenet database (Apr. 10, 1985).
Abstract for German Patent No. DE 19744027 A1, Schindler et al., “new Pyrazolo(3,4-b)pyridine Derivatives Useful as cGMP Agonists”, Derwent WPI database (Apr. 8, 1999).
Abstract for German Patent No. DE 4034762 A, Braun et al., “Pyridyl Pyrimidine Derivs.—are Fungicides for Plant Protection and for Protecting and Preserving Industrial Materials”, Derwent WPI database (May 7, 1992).
Abstract for German Patent No. DE 19756388 A, Schindler et al., “New 2-aryl-4-amino-6,7-dimethoxy-quinazoline Derivatives Useful as Guanylate Cyclase Activators for Treating Cardiovascular Diseases, etc.”, Derwent WPI database (Jun. 24, 1999).
Brown, Desmond J. et al., Heterocyclic Amplifiers of Phleomycin. I Some Pyrimidinylpurines, Pyrimidinylpteridines and Phenylpyrimidines,: Aust. J. Chem., 37:155-63 (1984).
Morel, Goerges et al., “2-Aza-1,3-Dienes with Electron-Relaesing Substituents at the 1,3 positions. Reagents for the Construction of Pyridine Derivatives.” Tetrahedron, 52:10095-10112 (1996).
Schnidler Ursula
Schoenafinger Karl
Strobel Hartmut
Aventis Pharma Deutschland GmbH
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Raymond Richard L.
LandOfFree
Substituted 4-amino-2aryl-pyrimidines, their production and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 4-amino-2aryl-pyrimidines, their production and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 4-amino-2aryl-pyrimidines, their production and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3423867